Compositions and methods for the treatment of fungal infections include compounds containing a β-1,3-glucan synthase inhibitor covalently conjugated to one or more monosaccharide or oligosaccharide moiety. In particular, compounds can be used in the treatment of fungal infections caused by a fungus in the genus Candida or Aspergillus.